Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Therapeutic Advances in Childhood Leukemia Consortium
National Institutes of Health Clinical Center (CC)
University of Wisconsin, Madison
National Cancer Institute (NCI)